Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Achieve TMS Alaska is a specialized healthcare provider that offers Transcranial Magnetic Stimulation (TMS) therapy for patients with treatment-resistant mental health conditions. The company primarily focuses on treating Major Depressive Disorder and Obsessive-Compulsive Disorder using FDA-cleared non-invasive brain stimulation technology. As part of the Greenbrook TMS network, the Alaska clinics utilize BrainsWay Deep TMS systems to target specific neurological pathways without the systemic side effects of medication. The service is designed for individuals who have not found relief through traditional antidepressants or psychotherapy. Achieve TMS Alaska operates multiple locations in the state, providing a clinical setting for daily treatment sessions administered by trained technicians under medical supervision. The organization plays a key role in expanding access to advanced neuromodulation therapies in the Pacific Northwest region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Achieve TMS Alaska.